All Clinical Trials
Mater conducts clinical trials in a range of therapeutic areas including Cance, Nerouology, Medicine, Orthopaedics Surgery and Acute Care, and Mothers' and Babies Health. Clinical trials are an essential component of helathcare. They provide the evidence to evaluate the safety and efficacy of new treantments and diagnositics, and provide alternative treatment options for patients with unmet needs.
Keynote-B15
The trial is testing a potential new treatment for Muscle-invasive Bladder Cancer.
lidERA - Trialing a new oral hormone receptor blocker in estrogen receptor positive breast cancer
Evaluating the efficacy and safety of post surgical Giredestrant compared with doctors choice of endocrine therapy (Tamoxifen, Anastrozole, Letrozole or Exemestane) in patients with estrogen receptor−positive, HER2-negative early breast cancer.
Light Knee Study - A randomized control trial examining photobiomodulation (PBM) therapy before and after knee replacement surgery.
Evaluating the efficacy and safety of post surgical Giredestrant compared with doctors choice of endocrine therapy (Tamoxifen, Anastrozole, Letrozole or Exemestane) in patients with estrogen receptor−positive, HER2-negative early breast cancer.
Lung ultrasound to direct chest physiotherapy in neonates
In neonates, how effective is lung ultrasonography in directing the use of CPT intervention when compared to the combination of CXR and auscultation?
Maplight - An experimental drug to moderate behavioural symptoms in people with autism
A clinical trial to investigate the efficacy, safety and tolerability of ML-004 for treatment of the core behavioural symptoms in Autistic people.
MedCan 3 - Medicinal cannabis to relieve symptoms of advanced cancer in palliative care patients
Medicinal cannabis to relieve symptoms of advanced cancer in palliative care patients.
Medical Oncology Trials
The Medical Oncology Clinical Research team, based within the Mater Cancer Care Centre, currently has 22 actively recruiting trials.
Medicinal cannabis for palliative care patients - exploring detection of cannabis in saliva, urine and blood tests.
Medicinal cannabis for advanced cancer patients – driving implications.
MK-1654 - Prophylactic treatment to prevent Respiratory Syncytial Virus infection in infants
A Phase 3, Multicenter, Randomized, Partially Blinded, Palivizumab Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of MK-1654 in Infants and Children at Increased Risk for Severe RSV Disease.
Nimble - Possible new medicine for Adults and Adolescents with Eosinophilic Asthma
A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype.